We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Adsorption Procedure Enhances Efficiency of Drug Transport

By LabMedica International staff writers
Posted on 31 Jul 2018
Print article
Image: Combining a nanocarrier with antibodies under acidic conditions results in the antibodies attaching to the drug carrier in a stable way. This makes it possible for nanocarriers to target diseased tissue (Photo courtesy of Stefan Schuhmacher).
Image: Combining a nanocarrier with antibodies under acidic conditions results in the antibodies attaching to the drug carrier in a stable way. This makes it possible for nanocarriers to target diseased tissue (Photo courtesy of Stefan Schuhmacher).
A simple adsorption procedure enhances the efficiency of nanocarrier transport of toxic drugs to tumors.

To promote drug delivery to exact sites and cell types, the surface of nanocarriers is functionalized with targeting antibodies or ligands, typically coupled by covalent chemistry. Once the nanocarrier is exposed to biological fluid such as plasma, however, its surface is inevitably covered with various biomolecules forming a protein corona, which masks the targeting ability of the nanoparticle.

To get around the protein-masking problem, investigators at Johannes Gutenberg University Mainz (Germany) developed a pre-adsorption process to attach targeting antibodies to the surface of the nanocarrier.

The investigators reported in the June 18, 2018, online edition of the journal Nature Nanotechnology that pre-adsorbed antibodies remained functional and were not completely exchanged or covered by the biomolecular corona, whereas coupled antibodies were more affected by this shielding.

"Up to now, we have always had to use elaborate chemical methods to bind these antibodies to nanocapsules," said senior author Dr. Volker Mailänder, head of the nanocarriers for medical applications group at the Johannes Gutenberg University Mainz. "We have now been able to show that all that you need to do is to combine antibodies and nanocapsules together in an acidified solution."

Related Links:
Johannes Gutenberg University Mainz

New
Gold Supplier
Fluorimetric Immunoassay Analyzer
Confiscope F20
New
Laboratory Automation System
FlexLab Automation
New
Gold Supplier
Centrifuge
Multifuge X4 Pro Centrifuge Series
New
Automated Urinalysis Solution
DxU Iris Workcell

Print article

Channels

Molecular Diagnostics

view channel
Image: The QuikRead go iFOBT is an immunochemical fecal immunochemical test for detection and quantification of human hemoglobin in feces in case of suspected bleeding from the lower gastrointestinal tract (Photo courtesy of Aidian)

Fecal Immunochemical Tubes Sourced to Analyze Gut Microbiome for CRC

Colorectal cancer (CRC) is a challenging public health problem which successful treatment depends on the stage at diagnosis. Recently, CRC-specific microbiome signatures have been proposed as a marker... Read more

Hematology

view channel
Image: Bone marrow aspirate from a patient with peripheral T-cell lymphoma (Photo courtesy of Peter Maslak, MD)

Mutation Analysis Links Angioimmunoblastic T-Cell Lymphoma to Clonal Hematopoiesis

Peripheral T-cell lymphoma (PTCL) is a heterogeneous group of lymphoid tumors and encompass peripheral T-cell lymphoma, not otherwise specified (PTCL-NOS), angioimmunoblastic T-cell lymphoma (AITL), and... Read more

Industry

view channel
Image: GastroPanel Quick Test (Photo courtesy of Biohit Healthcare)

Biohit’s Innovative GastroPanel Quick Test Receives CE Mark

Biohit Healthcare’s (Helsinki, Finland) GastroPanel Quick Test, the latest innovation in its unique GastroPanel product family, is now CE marked. The GastroPanel Quick Test is intended for diagnosing... Read more
Copyright © 2000-2021 Globetech Media. All rights reserved.